Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort

BACKGROUND: We investigated pretreatment fasting glucose as a predictor of patients’ important outcomes in breast and colorectal cancers undergoing targeted therapies. PATIENTS AND METHODS: In a historic cohort of 202 breast and 218 colorectal cancers treated with targeted agents from 1998 to 2009,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Barba, M., Sperati, F., Stranges, S., Carlomagno, C., Nasti, G., Iaffaioli, V., Caolo, G., Mottolese, M., Botti, G., Terrenato, I., Vici, P., Serpico, D., Giordano, A., D’Aiuto, G., Crispo, A., Montella, M., Capurso, G., Delle Fave, G., Fuhrman, B., Botti, C., De Placido, S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2012
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3387821/
https://ncbi.nlm.nih.gov/pubmed/22100694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdr540
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi